Cargando…

A metabolomic approach to identifying platinum resistance in ovarian cancer

BACKGROUND: Acquisition of metabolic alterations has been shown to be essential for the unremitting growth of cancer, yet the relation of such alterations to chemosensitivity has not been investigated. In the present study our aim was to identify the metabolic alterations that are specifically assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poisson, Laila M, Munkarah, Adnan, Madi, Hala, Datta, Indrani, Hensley-Alford, Sharon, Tebbe, Calvin, Buekers, Thomas, Giri, Shailendra, Rattan, Ramandeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396147/ https://www.ncbi.nlm.nih.gov/pubmed/25880539 http://dx.doi.org/10.1186/s13048-015-0140-8

Ejemplares similares

Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
por: Tebbe, Calvin, et al.
Publicado: (2014)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)

Dietary energy balance modulates ovarian cancer progression and metastasis
por: Al-Wahab, Zaid, et al.
Publicado: (2014)

Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
por: Udumula, Mary P., et al.
Publicado: (2022)

Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction
por: Al-Wahab, Zaid, et al.
Publicado: (2015)

Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
por: Hijaz, Miriana, et al.
Publicado: (2016)

Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response
por: Udumula, Mary Priyanka, et al.
Publicado: (2023)

Intermittent Fasting induced ketogenesis inhibits mouse epithelial ovarian tumors by promoting anti-tumor T cell response
por: Udumula, Mary Priyanka, et al.
Publicado: (2023)

Ovarian cancer modulates the immunosuppressive function of CD11b(+)Gr1(+) myeloid cells via glutamine metabolism
por: Udumula, Mary P., et al.
Publicado: (2021)

Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
por: Zahoor, Insha, et al.
Publicado: (2022)

Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
por: Rattan, Ramandeep, et al.
Publicado: (2012)

An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview
por: Zahoor, Insha, et al.
Publicado: (2021)

Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer
por: Giri, Shailendra, et al.
Publicado: (2014)

A patient perspective on applying intermittent fasting in gynecologic cancer
por: Redding, Ashley, et al.
Publicado: (2023)

Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis
por: Datta, Indrani, et al.
Publicado: (2021)

Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
por: Giri, Shailendra, et al.
Publicado: (2013)

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
por: Fitzgerald, Kathryn C., et al.
Publicado: (2021)

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis
por: Xia, Houjun, et al.
Publicado: (2020)

OTEH-12. Assessing Adaptive Responses to Loss of Extrachromosomal DNA Amplification
por: Berezovsky, Artem, et al.
Publicado: (2021)

Clinical trials and progress with paclitaxel in ovarian cancer
por: Kumar, Sanjeev, et al.
Publicado: (2010)

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
por: Rattan, R, et al.
Publicado: (2011)

AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model
por: Giri, Shailendra, et al.
Publicado: (2006)

Proteomic Profiles of Exosomes of Septic Patients Presenting to the Emergency Department Compared to Healthy Controls
por: Morris, Daniel C., et al.
Publicado: (2020)

PIK3CA alterations in Middle Eastern ovarian cancers
por: Abubaker, Jehad, et al.
Publicado: (2009)

Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB
por: Solomon, Leigh A, et al.
Publicado: (2008)

Impact of using real-world outcomes versus clinical evidence and list prices on value assessments
por: Meade, Denise, et al.
Publicado: (2019)

Cost of leukopenia and neutropenia in metastatic breast cancer within last 12, 36, and 60 months using a curated disease model
por: Alford, Sharon Hensley, et al.
Publicado: (2019)

Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy
por: Peng, Dongjun, et al.
Publicado: (2015)

Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection
por: Singh, Sukhvinder, et al.
Publicado: (2021)

OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
por: Brodie, Shlomit, et al.
Publicado: (2017)

Correction: The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
por: Brodie, Shlomit, et al.
Publicado: (2021)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

Exosomes as mediators of platinum resistance in ovarian cancer
por: Crow, Jennifer, et al.
Publicado: (2017)

ATR Inhibitors in Platinum-Resistant Ovarian Cancer
por: Li, Siyu, et al.
Publicado: (2022)

Ovarian Cancer—Insights into Platinum Resistance and Overcoming It
por: Havasi, Andrei, et al.
Publicado: (2023)

Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
por: Gonzalez-Ochoa, Eduardo, et al.
Publicado: (2023)

Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer
por: Cantón-Romero, Juan Carlos, et al.
Publicado: (2017)

Statistical Issues and Analyses of in vivo and in vitro Genomic Data in order to Identify Clinically Relevant Profiles
por: Poisson, Laila M., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_gp311u6bek4fm3or4bie73fahf